Lynn Cinelli is a globally respected healthcare and supply chain executive whose career spans over two decades of transformative leadership across biopharma operations, policy, and public health strategy. She currently leads global biologics supply at Bristol Myers Squibb, overseeing more than \$20 billion in annual revenue and pioneering digital and operational advancements that enhance product delivery and resilience. With a foundation in biological engineering and a proven track record at Merck in vaccines, policy, and global access, Lynn has consistently delivered strategic outcomes in complex, multinational environments. She is also a recognized champion of diversity and inclusion, an active board advisor, and a thought leader committed to building sustainable, high-performing systems that improve health outcomes worldwide.

Maryam Nourbakhsh is a seasoned project management leader with over 18 years of experience in the pharmaceutical and healthcare industries, specializing in strategic operations, clinical quality, and global regulatory compliance. She has a proven track record of driving complex initiatives, optimizing resource allocation, and implementing data-driven decision-making frameworks to enhance portfolio planning and operational efficiency. Currently serving as Director of Project Management at Bristol Myers Squibb, she spearheads innovative methodologies, fosters cross-functional collaboration, and ensures alignment with corporate objectives. With expertise spanning oncology, immunology, and hematology, Maryam has successfully led high-impact projects at leading pharmaceutical organizations, leveraging her knowledge in clinical trials, governance structures, and process improvement. Holding an MBA in Pharmaceutical Marketing and certifications in Lean Six Sigma and Change Management, she is a strategic thinker committed to innovation, operational excellence, and fostering a culture of continuous improvement.